AViTA Corporation (TPEX:4735)
30.50
-2.80 (-8.41%)
Nov 20, 2026, 1:30 PM CST
AViTA Revenue
AViTA had revenue of 316.80M TWD in the quarter ending September 30, 2026, with 34.08% growth. This brings the company's total for the last twelve months to 1.05B, up 17.43% year-over-year. In the year 2025, AViTA had annual revenue of 936.39M with 0.98% growth. That makes AViTA the 31,004th largest company in the world by revenue and 1,540th in Taiwan.
Revenue (ttm)
1.05B
Revenue Growth
+17.43%
P/S Ratio
1.12
Revenue / Employee
12.54M
Employees
84
Market Cap
1.17B
Revenue by Geography
- Europe 343.29M 36.7%
- America 334.40M 35.7%
- Asia, Australia and Other 258.70M 27.6%
Fiscal year ended Dec 31, 2025 See the full AViTA breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 936.39M | 9.09M | 0.98% |
| Dec 31, 2024 | 927.30M | 48.22M | 5.48% |
| Dec 31, 2023 | 879.08M | -321.84M | -26.80% |
| Dec 31, 2022 | 1.20B | -1.12B | -48.35% |
| Dec 31, 2021 | 2.33B | -274.96M | -10.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.82B |
| OK Biotech | 1.72B |
| Dynamic Medical Technologies | 1.42B |
| Bioptik Technology Incorporation | 891.73M |
| Medimaging Integrated Solution | 744.42M |
| Radiant Innovation | 417.97M |
| Wiltrom | 314.12M |
| S&S Healthcare Holding | 185.52M |